Top

Category: Biotech


Biotech, Industry

Bora Pharmaceuticals Adds Roller Compaction Capabilities

April 9, 2021

Via: Contract Pharma

Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility manufacturers complex oral solid dose (OSD) formulations with expertise […]


Biotech, Cell and Gene Therapy, Industry

HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration

April 6, 2021

Via: BioSpace

Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]


Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]


Biotech, FDA, Industry, Regulations

FDA Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 Clinical Development in COVID-19 Patients

April 5, 2021

Via: BioSpace

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that the U.S. Food and Drug Administration (FDA) has favorably reviewed the preclinical data package and clinical development plan […]


Biotech, Industry, News

Amgen acquires a small biotech and its inflammatory disease research

March 31, 2021

Via: Biopharma Dive

Amgen has recently stepped up its dealmaking activity as it tries to bolster its pipeline of treatments for cancer and inflammation. Earlier this month, the California biotech announced plans to pay $1.9 billion for Five Prime Therapeutics, which is focused […]


Biotech, Industry

Biotechs Bolstering Bank Accounts by Selling Stock This Week

March 25, 2021

Via: BioSpace

Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days, with Dutch biotechnology company LAVA Therapeutics leading the pact. LAVA, a company harnessing expertise in bispecific […]


Biotech, Industry, News

CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight Blood Test for Detection of Colorectal Cancer and Pre-Cancer

March 23, 2021

Via: BioSpace

CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a strategic development and commercial collaboration agreement, as well as CellMax’s Series […]


Biotech, Clinical Trials, Industry, Research and Development

A first-of-its-kind mRNA drug falls short in cystic fibrosis

March 18, 2021

Via: Biopharma Dive

Messenger RNA technology, which uses synthetic, genetic material to teach the body to make helpful proteins, has come of age over the past year. When the coronavirus pandemic took hold in 2020, the technology was uniquely suited to meet the […]


Biotech, FDA, Industry, Regulations

FDA approves first-of-its-kind lupus drug

January 25, 2021

Via: Biopharma Dive

While estimates vary, the Lupus Foundation of America figures that 1.5 million people in the U.S. and at least 5 million people worldwide are affected by the autoimmune disease. Despite the prevalence of the condition, however, there remains relatively few […]


Biotech, Industry

Genetic Engineering Across the Tree of Life

September 21, 2020

Via: Genetic Engineering and Biotechnology News

Industrial bioengineering is now using genetically modified microbes to produce a wide array of products at industrial scale, including everything from biofuels to nutraceuticals such as resveratrol. But despite the diversity of output, the primary organisms producing them are modified […]


Biotech, Industry

A new biotech forms to revive Amgen’s old heart drug

August 26, 2020

Via: Biopharma Dive

It wasn’t that long ago that CETP inhibitors were the next big thing in heart medicine. The drugs were part of a bet by researchers that raising the levels of high-density lipoprotein (HDL), also known as “good” cholesterol, might be […]


Biotech, Industry

AI Can Aid Biopharma, but Industry Must Remember the Science

August 25, 2020

Via: Genetic Engineering and Biotechnology News

Artificial intelligence (AI) has huge potential in bioprocessing. Its ability to model process data in real-time and feed this information into automated control systems is attractive to efficiency-focused drug companies. According to a recent report, biopharma companies are warming to […]